NYMOX corporation risk reaches “an extreme high” – CM Labs

Nymox Pharmaceutical {NASDAQ: NYMX} corporate risk has been rated as “extremely high” by Capital Market Laboratories.

The data is drawn from many ppints within the option market.

The full article can be read here:

Read the full article HERE